| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
2681 |
| issn |
1744-7666
1465-6566 |
| issueIdentifier |
15 |
| pageRange |
2673-2681 |
| publicationName |
Expert Opinion on Pharmacotherapy |
| startingPage |
2673 |
| bibliographicCitation |
You JH, Chan FW. Pharmacoeconomics of entecavir treatment for chronic hepatitis B. Expert Opin Pharmacother. 2008 Oct;9(15):2673–81. doi: 10.1517/14656566.9.15.2673. PMID: 18803453. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d074faf56de4102f367c148dfeb99471
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e36c402aa6213b1974836fbbb252f023 |
| date |
2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1517/14656566.9.15.2673
https://pubmed.ncbi.nlm.nih.gov/18803453 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1744-7666
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22235
https://portal.issn.org/resource/ISSN/1465-6566 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Pharmacoeconomics of entecavir treatment for chronic hepatitis B |
| discusses |
http://id.nlm.nih.gov/mesh/M0370336
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0009679 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D017850
http://id.nlm.nih.gov/mesh/D006147Q000031
http://id.nlm.nih.gov/mesh/D000998Q000627
http://id.nlm.nih.gov/mesh/D019694Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006147Q000191
http://id.nlm.nih.gov/mesh/D006147Q000627
http://id.nlm.nih.gov/mesh/D019057
http://id.nlm.nih.gov/mesh/D000998Q000191
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 |